Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,456 | 529 | 99.6% |
| Education | $41.98 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,727 | 104 | $0 (2024) |
| Amgen Inc. | $1,322 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,179 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $800.53 | 43 | $0 (2022) |
| Novo Nordisk Inc | $610.24 | 28 | $0 (2024) |
| ABBVIE INC. | $552.70 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $510.39 | 33 | $0 (2023) |
| Lilly USA, LLC | $452.24 | 23 | $0 (2024) |
| Esperion Therapeutics, Inc. | $433.75 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $379.40 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,380 | 70 | ABBVIE INC. ($277.03) |
| 2023 | $1,290 | 59 | GlaxoSmithKline, LLC. ($297.68) |
| 2022 | $1,606 | 74 | Novo Nordisk Inc ($300.16) |
| 2021 | $1,501 | 73 | PFIZER INC. ($239.52) |
| 2020 | $1,046 | 58 | GlaxoSmithKline, LLC. ($288.05) |
| 2019 | $1,320 | 68 | PFIZER INC. ($353.01) |
| 2018 | $1,270 | 61 | Janssen Pharmaceuticals, Inc ($273.53) |
| 2017 | $1,085 | 70 | PFIZER INC. ($437.66) |
All Payment Transactions
533 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 4,250 | 7,891 | $874,732 | $384,526 |
| 2022 | 56 | 4,827 | 9,112 | $961,814 | $442,365 |
| 2021 | 55 | 5,369 | 10,024 | $1.0M | $481,638 |
| 2020 | 58 | 5,578 | 10,239 | $1.0M | $466,848 |
All Medicare Procedures & Services
215 procedure records from CMS Medicare Utilization — Page 6 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82746 | Folic acid level, serum | Office | 2021 | 124 | 183 | $7,320 | $2,690 | 36.8% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 52 | 66 | $5,280 | $2,217 | 42.0% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 28 | 28 | $4,200 | $2,167 | 51.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 43 | 46 | $4,140 | $2,030 | 49.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 23 | 23 | $2,875 | $1,962 | 68.3% |
| 82306 | Vitamin d-3 level | Office | 2021 | 65 | 65 | $7,800 | $1,924 | 24.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 63 | 175 | $6,125 | $1,818 | 29.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 27 | 28 | $3,360 | $1,671 | 49.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 66 | 66 | $2,310 | $1,255 | 54.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 93 | 122 | $4,880 | $1,175 | 24.1% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 27 | 30 | $3,000 | $1,116 | 37.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 62 | 63 | $2,205 | $1,088 | 49.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 181 | 349 | $2,792 | $1,029 | 36.9% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | Office | 2021 | 63 | 79 | $3,160 | $1,023 | 32.4% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 55 | 69 | $2,415 | $940.47 | 38.9% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2021 | 17 | 17 | $1,020 | $768.91 | 75.4% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 35 | 40 | $1,570 | $706.33 | 45.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 11 | $1,430 | $661.65 | 46.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 58 | 63 | $3,780 | $654.63 | 17.3% |
| 83550 | Iron binding capacity | Office | 2021 | 45 | 56 | $2,240 | $489.44 | 21.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2021 | 62 | 70 | $1,050 | $398.82 | 38.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 62 | 71 | $1,065 | $367.78 | 34.5% |
| 83540 | Iron level | Office | 2021 | 45 | 56 | $1,680 | $362.32 | 21.6% |
| 84550 | Uric acid level, blood | Office | 2021 | 61 | 79 | $1,185 | $352.66 | 29.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 18 | 18 | $756.00 | $347.58 | 46.0% |
About Dr. Nicolas Marsheh, M.D
Dr. Nicolas Marsheh, M.D is a Internal Medicine healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962423657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicolas Marsheh, M.D has received a total of $10,498 in payments from pharmaceutical and medical device companies, with $1,380 received in 2024. These payments were reported across 533 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($10,456).
As a Medicare-enrolled provider, Marsheh has provided services to 20,024 Medicare beneficiaries, totaling 37,266 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 215 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Sterling Heights, MI
- Active Since 07/21/2006
- Last Updated 04/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962423657
Products in Payments
- XARELTO (Drug) $705.45
- TRELEGY ELLIPTA (Drug) $700.12
- ELIQUIS (Drug) $649.19
- Otezla (Drug) $505.28
- ENTRESTO (Drug) $493.23
- VRAYLAR (Drug) $440.22
- Repatha (Biological) $375.14
- CHANTIX (Drug) $337.27
- LYRICA (Drug) $331.60
- Ozempic (Drug) $322.97
- NEXLETOL (Drug) $313.70
- Aimovig (Biological) $276.56
- Vascepa (Drug) $232.60
- Rybelsus (Drug) $217.36
- COLOGUARD (Device) $203.23
- Cologuard Collection Kit (Device) $199.74
- MOUNJARO (Drug) $184.38
- ANORO ELLIPTA (Drug) $161.12
- AJOVY (Biological) $152.63
- TOUJEO (Drug) $141.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sterling Heights
Dr. Syed Ali Muttaqi Husain, M.d, M.D
Internal Medicine — Payments: $54,045
Sandeep Garg, Md, MD
Internal Medicine — Payments: $37,573
Dr. Sami Asmar, M.d, M.D
Internal Medicine — Payments: $13,662
Dr. Zbigniew Purzycki, M.d, M.D
Internal Medicine — Payments: $12,572
Dr. Victor Al-Matchy, M.d, M.D
Internal Medicine — Payments: $12,259
Mazen Alsaqa, M.d, M.D
Internal Medicine — Payments: $9,495